Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy

BACKGROUND: Minimal improvements in treatment or survival of patients with osteosarcoma have been achieved during the last three decades. Especially in the case of incomplete tumor resection, prognosis remains poor. Heavy ion radiotherapy (HIT) and modern anticancer drugs like histone deacetylase in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Radiat Oncol
Autors principals: Blattmann, Claudia, Oertel, Susanne, Thiemann, Markus, Dittmar, Anne, Roth, Eva, Kulozik, Andreas E., Ehemann, Volker, Weichert, Wilko, Huber, Peter E., Stenzinger, Albrecht, Debus, Jürgen
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4504102/
https://ncbi.nlm.nih.gov/pubmed/26178881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-015-0455-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars